Within females, basal CRP levels greater than 1 mg L−1 are suggested to increase the risk of endothelial damage, myocardial infarction, thromboembolic events, and atrial fibrillation and have been used as a clinical threshold to determine cardiovascular disease risk (Cauci et al., 2017). The gene discussed is CRP; the disease is cardiovascular disorder.